Date | Time | Place | Session / Title | Role |
April 28 | 10:15 AM - 11:40 AM | Main Arena, Level 3 | Live Case Session II | Discussant |
April 28 | 3:10 PM - 4:35 PM | Presentation Theater 1, Level 1 | DES, BRS and DCB | Panelist |
April 28 | 3:26 PM - 3:34 PM | Presentation Theater 1, Level 1 | DES, BRS and DCB Data and Application of Ultra-Thin Strut DES: Is It Also Working for Complex Lesions? |
Lecturer |
April 28 | 4:35 PM - 6:00 PM | Presentation Theater 1, Level 1 | Renal Denervation & LAA Closure | Moderator |
April 28 | 4:43 PM - 4:51 PM | Presentation Theater 1, Level 1 | Renal Denervation & LAA Closure Results and Update from the SPYRAL Hypertension Program(OFF-MED and ON-MED Trials) |
Lecturer |
April 29 | 8:30 AM - 10:00 AM | Coronary Theater, Level 1 | Live Case & Lecture Session II | Discussant |
April 29 | 11:00 AM - 11:45 AM | Presentation Theater 1, Level 1 | TCTAP 2019-Featured Clinical Research from Abstracts | Discussant |
April 29 | 11:08 AM - 11:15 AM | Presentation Theater 1, Level 1 | TCTAP 2019-Featured Clinical Research from Abstracts Discussion: [TCTAP A-001] A Novel Atrial Fibrillation Prediction Model for Asian Subjects - A Nationwide Cohort Study |
Discussant |
April 29 | 12:45 PM - 1:45 PM | Coronary Theater, Level 1 | Delivering More Innovation of the Interventional Portfolio, Further Together | Moderator |
April 29 | 1:05 PM - 1:20 PM | Coronary Theater, Level 1 | Delivering More Innovation of the Interventional Portfolio, Further Together Renal Denervation: Latest Clinical Evidence and Update |
Lecturer |